What's the most recent regulatory action in Infection by Onchocerca volvulus?

Most recent: Stromectol — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/infection-by-onchocerca-volvulus.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Infection by Onchocerca volvulus — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infection by Onchocerca volvulus (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Infection by Onchocerca volvulus, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Moxidectin	MOXIDECTIN	Mdgh			2018-01-01
Caricide	DIETHYLCARBAMAZINE	Pfizer	Anthelmintic	Arachidonate 5-lipoxygenase	1950-01-01
Stromectol	ivermectin	Merck & Co.	Antiparasitic [EPC]	Adenosine receptor A3, Multidrug resistance protein 1, Neuronal acetylcholine receptor subunit alpha-7

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-04-07 — Stromectol · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Mdgh · 1 drug in Infection by Onchocerca volvulus
Merck & Co. · 1 drug in Infection by Onchocerca volvulus
Pfizer · 1 drug in Infection by Onchocerca volvulus

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Infection by Onchocerca volvulus:

Cite this brief

Drug Landscape (2026). Infection by Onchocerca volvulus — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/infection-by-onchocerca-volvulus. Accessed 2026-06-10.

Infection by Onchocerca volvulus full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing